Skip to content

Evaluation of the effect of prioperative intravenous lidocaine infusion on post operative pain and analgesic requirement in tibial fracture surgery

Evaluation of the effect of prioperative intravenous lidocaine infusion on post operative pain and analgesic requirement in tibial fracture surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201104306337N1
Enrollment
48
Registered
2011-09-22
Start date
2010-10-12
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain relief after tibial fracture surgery. Acute pain

Interventions

Intervention 1: Patient s in control group received normal saline IV infusion. Intervention 2: Patients in intervention group received lidocaine (lidocaine group) with a 1.5 mg/kg intravenous bolus an
Placebo
Prevention
Patient s in control group received normal saline IV infusion
Patients in intervention group received lidocaine (lidocaine group) with a 1.5 mg/kg intravenous bolus and followed by a 1.5 mg . kg intravenous infusion

Sponsors

Ahvaz Jundishapur University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: patients undergoing tibial fracture surgery under general anesthesia; age 18-50inclusive; ASA class I patients ; Body Mass Index (BMI) of 18.5-35 (Includes 18.5 to 25 – healthy range; >25-30 overweight; >30-35 Obese Class I); Exclusion Criteria: patients under age 18 or over age50; ASA,II III, IV and V class patients ; Obese Class II patients (BMI>35) or undernourished (BMI<18.5); history of Liver dysfunction ; renal insufficiency; history of seizure disorder; hypersensitivity or allergy to amide type local anesthetics; medication use(daily use of any opiods or analgesic) and any chronic pain syndromes ;

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pethedine consumpsion. Timepoint: 1, 2, 4, 12 , 16 , 20 and 24 hours post extubation. Method of measurement: Medical records.

Secondary

MeasureTime frame
Pain. Timepoint: 1, 2, 4, 12 , 16 , 20 and 24 hours after extubation. Method of measurement: Visual analog scale (VAS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Sholeh Nesioonpour

Ahvaz Jundishapur University of Medical Sciences

Dr.nesioun@yahoo.com+98 61 1222 2114

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026